Brandes Investment Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $162M | Sell |
343,224
-43,607
| -11% | -$22M | 1.15% | 31 |
|
|
2025
Q4 | $181M | Sell |
386,831
-14,225
| -4% | -$6.6M | 1.37% | 22 |
|
|
2025
Q3 | $171M | Buy |
401,056
+35,367
| +10% | +$13.7M | 1.37% | 22 |
|
|
2025
Q2 | $140M | Sell |
365,689
-8,050
| -2% | -$2.9M | 1.27% | 27 |
|
|
2025
Q1 | $129M | Buy |
373,739
+9,633
| +3% | +$3.1M | 1.31% | 26 |
|
|
2024
Q4 | $109M | Sell |
364,106
-8,952
| -2% | -$3.13M | 1.22% | 29 |
|
|
2024
Q3 | $152M | Buy |
373,058
+6,467
| +2% | +$2.37M | 1.7% | 18 |
|
|
2024
Q2 | $118M | Buy |
366,591
+23,748
| +7% | +$7.72M | 1.46% | 25 |
|
|
2024
Q1 | $114M | Buy |
342,843
+29,097
| +9% | +$8.89M | 1.47% | 25 |
|
|
2023
Q4 | $84.9M | Buy |
313,746
+104,774
| +50% | +$25.9M | 1.29% | 30 |
|
|
2023
Q3 | $51.4M | Buy |
208,972
+6,693
| +3% | +$1.83M | 1% | 36 |
|
|
2023
Q2 | $61.4M | Sell |
202,279
-113,930
| -36% | -$31.7M | 1.24% | 28 |
|
|
2023
Q1 | $83.4M | Buy |
316,209
+47,403
| +18% | +$12M | 1.77% | 18 |
|
|
2022
Q4 | $64.5M | Sell |
268,806
-34,703
| -11% | -$7.77M | 1.81% | 21 |
|
|
2022
Q3 | $55.8M | Buy |
303,509
+26,017
| +9% | +$5.18M | 1.46% | 22 |
|
|
2022
Q2 | $46.6M | Buy |
277,492
+5,354
| +2% | +$1.15M | 1.14% | 31 |
|
|
2022
Q1 | $68.2M | Sell |
272,138
-6,359
| -2% | -$1.6M | 1.46% | 24 |
|
|
2021
Q4 | $71.6M | Sell |
278,497
-8,315
| -3% | -$2.03M | 1.56% | 18 |
|
|
2021
Q3 | $69.6M | Sell |
286,812
-103,645
| -27% | -$25.3M | 1.51% | 19 |
|
|
2021
Q2 | $80.7M | Buy |
390,457
+29,631
| +8% | +$6.04M | 1.79% | 11 |
|
|
2021
Q1 | $68M | Sell |
360,826
-12,037
| -3% | -$2.12M | 1.61% | 13 |
|
|
2020
Q4 | $60.5M | Sell |
372,863
-16,044
| -4% | -$2.35M | 1.56% | 15 |
|
|
2020
Q3 | $48.5M | Sell |
388,907
-69,667
| -15% | -$8.62M | 1.68% | 21 |
|
|
2020
Q2 | $44.5M | Sell |
458,574
-9,128
| -2% | -$949K | 1.36% | 28 |
|
|
2020
Q1 | $42M | Buy |
467,702
+90,035
| +24% | +$11.7M | 1.47% | 22 |
|
|
2019
Q4 | $55.8M | Sell |
377,667
-11,786
| -3% | -$1.58M | 1.33% | 27 |
|
|
2019
Q3 | $46.9M | Sell |
389,453
-13,547
| -3% | -$1.75M | 1.21% | 26 |
|
|
2019
Q2 | $54.5M | Sell |
403,000
-18,482
| -4% | -$2.34M | 1.21% | 25 |
|
|
2019
Q1 | $55M | Sell |
421,482
-3,947
| -0.9% | -$530K | 1.28% | 25 |
|
|
2018
Q4 | $52.9M | Sell |
425,429
-152,047
| -26% | -$20.4M | 1.35% | 23 |
|
|
2018
Q3 | $80.3M | Sell |
577,476
-26,844
| -4% | -$3.34M | 1.81% | 16 |
|
|
2018
Q2 | $62M | Sell |
604,320
-42,460
| -7% | -$4.3M | 1.4% | 24 |
|
|
2018
Q1 | $62.8M | Sell |
646,780
-29,055
| -4% | -$2.82M | 1.34% | 29 |
|
|
2017
Q4 | $59.4M | Sell |
675,835
-11,133
| -2% | -$894K | 1.2% | 30 |
|
|
2017
Q3 | $54.7M | Buy |
686,968
+560,144
| +442% | +$45M | 1.11% | 31 |
|
|
2017
Q2 | $11.1M | Buy |
+126,824
| New | +$10.7M | 0.17% | 80 |
|
Other funds holding HCA
VCM
VPM
Brandes Investment Partners's HCA Position: Q1 2026 in Review
Brandes Investment Partners reduced its HCA Healthcare (HCA) stake by 11% in Q1 2026, selling an estimated $22M and leaving 343,224 shares worth $162M. The position accounts for 1.15% of the portfolio, ranked #31.
Brandes Investment Partners first reported a position in HCA in Q2 2017 and has held it in 36 quarters since. The position peaked at $181M in Q4 2025. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Brandes Investment Partners held 343,224 shares of HCA Healthcare worth $162M as of Q1 2026.
- Brandes Investment Partners sold 43,607 HCA Healthcare shares in Q1 2026, an estimated $22M.
- HCA Healthcare made up 1.15% of Brandes Investment Partners's portfolio in Q1 2026, its #31 holding.
- Brandes Investment Partners first reported a position in HCA Healthcare in Q2 2017 and has held it in 36 quarters since.
- Brandes Investment Partners's HCA Healthcare position peaked at $181M in Q4 2025.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.